NORDIC BIOTECH INCENTIVE ApS: Financial statements 2017
CVR: 26277779
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
NORDIC BIOTECH INCENTIVE ApS (CVR 26277779) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 51,133,497 and a net result of DKK 5,256,705 compared with DKK -58,338,775 the year before. Equity in the 2017 report amounted to DKK 26,897,321. The solvency ratio was 99.8%.
- Gross Profit
- DKK 51,133,497
- Profit/Loss
- DKK 5,256,705
- Equity
- DKK 26,897,321
- Total Assets
- DKK 26,963,444
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 51.1 mio. | 5.3 mio. | 26.9 mio. | - |
| 2016 | - | -21 t. | -58.3 mio. | 72.6 mio. | - |
| 2015 | - | -20 t. | 24.2 mio. | 130.9 mio. | - |
| 2014 | - | -16 t. | 86.1 mio. | 106.7 mio. | - |
| 2013 | - | -12 t. | 12.5 mio. | 20.6 mio. | - |
Official annual report
Keep an eye on NORDIC BIOTECH INCENTIVE ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
NORDIC BIOTECH INCENTIVE ApS has published its annual report for 2016. Gross profit came to DKK -21,250, and the net result was DKK -58,338,775.
About NORDIC BIOTECH INCENTIVE ApS
NORDIC BIOTECH INCENTIVE ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2001. The company is in liquidation. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Jakob Mosegaard Larsen. The company's owners include Lars Grønborg Eskesen, Thue Walter Schwartz and CADENZA PARTNERS ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -397,188 and a net result of DKK -719,666 compared with DKK 4,871,034 the year before. Equity in the 2025 report amounted to DKK 5,834,302.